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Abstract
One out of four people age 65 and older residing in a long term care facility (LTCF) has Type 2
diabetes (T2DM) (Smide & Nygren, 2013). Care and management of this population is a
challenge for nurses and other providers. Results of a needs assessment in a local LTCF
identified deficiencies in the provision of evidence-based T2DM care for this target population.
American Diabetes Association Guidelines (2017) recommend application of individualized
HbA1c targets for the elderly residing in LTCFs, especially for those with compromises in
clinical and functional status. This two-prong quality improvement project strove to educate
nurses about these residents’ needs, and incorporate the use of best practice diabetes standards in
the nurse practitioner’s practice. Specifically, emphasis was placed on HbA1c and finger stick
monitoring, eye exams, and foot care. Results indicated that educational in-services designed for
nurses were an effective approach to improving knowledge concerning care of complex TD2M
patients. Although ophthalmology and podiatry referrals were not ordered routinely because of
APRN, staff, and organizational resistance; utilization of standardized orders improved routine
T2DM care pertaining to ordering HbA1c, renal panel, and urine to albumin creatinine ratio. The
APRN now has the awareness to evaluate discrepancies between HbA1c results and finger stick
values. QI projects in LTCF’s may be difficult to implement and sustain related to staff turnover,
understaffing, high patient acuity, and organizational and provider opposition. APRNs must
advocate for continual utilization of evidence-based practice guidelines for all LTC residents.
Keywords: Type 2 diabetes, long term care facility, American Diabetes Association Guidelines
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Overview of the Problem
The burden of diabetes is staggering. The Centers for Disease Control (CDC, 2014) report
that in all age categories, approximately 29.1 million (9.3%) of the U.S. population is touched by
diabetes; which includes the people diagnosed (21.0 million) and undiagnosed (8.1. million) with the
disease. Diabetes was the seventh leading cause of death in 2011 and cost the U.S. $176 billion in
direct costs and $69 billion in indirect costs. Indirect costs include disability, work loss, and
premature death (Jones et al., 2014).
The CDC (2015a) asserts that for the last 34 years (1980-2014), there has been a sustained
increase in the number of Americans diagnosed with type 2 diabetes (T2DM) (5.5 million to 22
million). By age, the prevalence of T2DM in Americans aged 65 and older was reported at 11.2
million (diagnosed and undiagnosed) or 25.9% of the U.S. population (American Diabetes
Association [ADA], 2017b). The number of new cases was reported at 400,000 per year in 2012 at
an unadjusted rate of 11.5 persons per 1,000 new cases (CDC, 2015b).
The Administration on Aging (2016) cited that in 2014, the proportion of the U.S. population
aged 65 years and older accounted for 46.2 million, which represented 14.5% of the U. S. population
(one in every seven Americans). The period between 2004-2014 indicated that the number of
Americans who will reach the age of 65 over the next two decades is estimated to rise to 17.7%
while those aged 60 and over will increase from 48.9 to 64.8 million (32.5%). Life expectancy rates
for persons reaching the age of 65 have also lengthened an additional 19.3 years (20.5 years for
females and 18 years for males). Projected estimates calculate that a child born in 2014 may live to
78.8 years, which is 30 more years than a child who was born in 1900. This immense explosion of
the aging population is of critical significance in nursing and healthcare because diabetes mellitus
affects over 20% of people over the age of 65 (Huang, 2016, p. 1).
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For the state of Texas, data from the Texas Department of State Health Services (2016)
indicates that the unadjusted prevalence rate of diabetes for Texas residents was at 11% (derived
from a total population of 26,448,193) and it was found to be more common in Hispanics than
whites. The annual age-adjusted death rates for all ages per 100,000 persons attributable to diabetes
was recorded at 5,262 and was more than twice as likely to occur in blacks than whites. Hispanics
were twice as likely to die from diabetes as whites. The annual age-adjusted hospitalization rate for
adults 18 years and older with diabetes was reported at 12 per 100,000 adults (95% confidence
interval) with a total cost burden over $280 million in Medicaid dollars spent (total combines
inpatient and outpatient care and professional fees) which averages $1,113.62 in reimbursement per
beneficiary (Texas Department of State Health Services, 2016).
Diabetes is a complicated disease. It is complicated by other co-existing conditions and
complications including hypoglycemia, hyperglycemia, hypertension, hyperlipidemia, heart disease,
stroke, blindness and visual problems, kidney disease, amputation, neuropathy, non-alcoholic fatty
liver disease, periodontal disease, erectile dysfunction, hearing loss, and depression all of which
makes its management inherently problematic (Jones, Hines, Narva, & Albright, 2014). Of the
complications previously specified, cardiovascular disease (heart disease or stroke), blindness and
other eye problems, kidney disease, and lower limb amputations are among the top four diabetesrelated complications. The CDC (2014) reported the number of people in the U.S. age 35 years and
older with diabetes and self-reported heart disease or stroke rose from 4.2 million to 7.6 million from
1997-2011. In 2011, 5 million people with diabetes stated having coronary heart disease, 3.7 million
confirmed having other heart disease or condition, and 2.1 million confirmed having had a stroke.
The number of adults aged 18 years or older with diagnosed diabetes reporting visual impairment
from 1997-2011 increased from 2.7 million to 4.0 million. Data regarding the true prevalence
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estimates of self-reported visual impairment may have been underestimated since approximately
25% of individuals with diabetes have not been formally diagnosed (CDC, 2014).
Diabetes-associated chronic kidney disease (CKD) is estimated to affect more than 20
million adults and was the ninth leading cause of death in the U. S. Overall, the prevalence of CKD
increased from 12% to 14% between 1988 and 1994. From 1999 to 2004, the rate has remained
relatively stable (National Institute of Diabetes and Digestive and Kidney Diseases [NIDDK], 2016).
NIDDK (2016) described the largest increase since 1988 (4.5% to 6%) occurred in people with Stage
3 CKD. From 1980 to 2008, the number of persons initiating treatment for end-stage-renal-disease
(ESRD) related to diabetes increased from over 2,600 to 48,374 in 2008. However, the rate of new
cases since 1999 has decreased (CDC, 2014).
Ortman, Velkoff, and Hogan (2014) cited that T2DM in the elderly is an alarming health
issue because the elderly population age 65 and older is calculated to double from 43.1 million to
83.7 million between 2012-2050. This exponential increase has been attributed to the aging baby
boomers who started turning 65 in 2011 (Ortman et al., 2014). Due to the expansive growth of this
older adult population, it is anticipated that the utilization of nursing facilities, alternative residential
care facilities, or home care services will rise from 15 million to 27 million between 2000-2050
(CDC, 2016). More than two-thirds of this aging population will require some type of long term care
facility (LTCF) services during their lifetime with a 46% possibility of residing in a nursing home
(CDC, 2016).
Data regarding the number of Americans aged 65 and older requiring LTCF services are of
remarkable significance for health care providers considering that one out of four Americans aged 65
and older who resides in nursing homes has T2DM and may receive substandard care (Smide &
Nygren, 2013). Vijan, Sussman, Yudkin, and Hayward (2014) conducted a chart review of 245 cases
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in 14 extended care facilities and found that the management of T2DM did not meet the
recommended ADA standards of care for ambulatory adults. The authors also found that despite
36.7% of the residents meeting the target A1c goal, the effect of glucose variability on the A1c
results was not accounted for. Likewise, Garcia and Brown (2011) conducted a systematic review of
literature of 20 studies from six countries (predominantly in the U. S.) regarding the diabetes
management in nursing homes or long term care settings. The results showed that there were varying
levels of management practices and adherence to the recommended standards of care for T2DM and
disease management was sporadic at best. Estimates indicate that the pervasiveness of T2DM in
LTCFs in the U.S. is at 33.3% for those who are 65 years and older (Vajen et al., 2012). It is
imperative that health care providers in this arena are properly trained to deliver high quality T2DM
care.
Background of the Problem
De Fronzo (2009) stated that T2DM is a chronic progressive disease characterized by insulin
resistance in the muscle and liver with beta cell failure as the central components of the disease
process (otherwise known as the triumvirate). Patients in the top tiers of impaired glucose tolerance
and at the highest strata of insulin resistance have over 80% loss of their beta cells which intimate
that beta cell failure evolves at a much more expeditious and serious rate than previously speculated.
The aforementioned trifecta is cited as the underlying core defect implicated in the development and
progression of T2DM but its pathogenesis has now expanded to the paradigm of the Ominous Octet.
The triumvirate (liver, muscle, and beta cell) now encompass the circuitous involvement of the fat
cell (accelerated lipolysis), gastrointestinal tract (incretin/deficiency/resistance), alpha cell
(hyperglucagonemia), kidneys (increased glucose reabsorption), and brain (insulin resistance) in the
development and progression of T2DM (Figure 1).
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Figure 1. The Ominous Octet. This figure illustrates the development and progression of T2DM.
Reprinted from “From the triumvirate to the ominous octet: A new paradigm for the
treatment of type 2 diabetes mellitus,” by R. De Fronzo, 2009, Diabetes, 58, p. 782. Copyright 2009
by the American Diabetes Association.

Care for the elderly with T2DM diabetes mellitus requires special considerations due to agerelated co-morbid complications in this vulnerable group including polypharmacy, decreased renal
function, high risk for falls, poor vision, and cognitive decline (ADA, 2017a, p. 99). The current
consensus regarding the treatment goals for the elderly is centered on individualizing glycemic
targets based on their clinical and functional conditions (ADA, 2017a). The implicit expectation is,
for those elderly patients who are cognitively and functionally intact and have reasonable life
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expectancy rates, disease management should be similar to those standards established for younger
adults (ADA, 2017a). Davis, Wenhui, Meyers, Kilpatrick, and Pandya (2014) noted that several
organizations have made varying recommendations on the use of alternative Hemoglobin A1c
(HbA1c) targets for older adults (65 and older) in poor health status (two or more co-morbid
conditions and functional limitations). The ADA (2017a) advocates a desirable HbA1c target of
<8.5% for elderly adults in LTCF, while organizations such as the Diabetes Program of Nova Scotia
in concert with the Palliative and Therapeutic Harmonization program recommend targets be
adjusted to >8.0% but lower than 12% depending on circumstances that complicate the care. CVAs
and myocardial infarctions are among the deadly complications associated with hypoglycemia in this
population. Likewise, the International Association of Gerontology and Geriatrics, the European
Diabetes Working Party for Older People, along with an international taskforce of diabetes experts
inferred the desirable HbA1c target for older adults aged 70 or older should be 7.0% -7.5% with
further relaxation for those who live in LTCF (Davis et al., 2014). For the purpose of this project
proposal, the 2017 ADA journal supplement Standards of Medical Care in Diabetes (ADA, 2017a)
is utilized as the benchmark guideline for evaluation of care (Table 1).
Synopsis of the Microsystem
To shed some light on the T2DM care of the elderly in LTCFs, a needs assessment was
conducted in a nursing home in southwest Texas to determine if its elderly residents ages 65 and
above who had diabetes and other co-morbid conditions and functional limitations were receiving
age-appropriate diabetes care based on the most current ADA guidelines. The nursing home is a forprofit, 126 bed LTCF that had an occupancy rate of 86 patients at the time the needs assessment was
conducted. The facility is nestled within a quiet residential neighborhood and is 8.3 miles away (16
minutes) from the nearest hospital. The facility is part of a leading healthcare and rehabilitation
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Table 1
ADA diabetes treatment guidelines
_____________________________________________________________________________________
Condition
Complication
Frequency
_____________________________________________________________________________________________
Blood glucose control
HbA1c
Every 3 months until the target
level is reached; thereafter,
patients should be monitored
at least every 12 months
_____________________________________________________________________________________________
Foot ulcers
Physical exam focused on
Patients at very high risk
ankle reflexes, dorsalis
should be seen every 3
pedis pulse, vibratory sensation,
months by a wound care
and 5.07 monofilament touch
nurse. Patients at increased
sensation performed by a
risk and average risk should
provider qualified to
be screened annually
determine the level of risk for
foot ulcers
_____________________________________________________________________________________________
Microalbuminuria
Microalbumin/creatinine ratio
Annually
_____________________________________________________________________________________________
Retinopathy
Dilated eye exam by a trained
Patients with evidence of
eye services professional or
retinopathy should be screened
Nondilated digital photography
annually. Patients without evidence
followed by a comprehensive
of retinopathy should be screened
exam for those who test positive every 2 years
_____________________________________________________________________________________________
Electrolyte and chemistry
Serum creatinine and serum
At least annually
abnormalities
potassium

_____________________________________________________________________________________

Note. Retrieved from Diabetes Care. Copyright 2017 by the American Diabetes Association.

service provider for the elderly composed of 19 other LTCFs throughout Texas. The facility
provides area residents with access to hospice/palliative care, rehabilitation services, respite care,
skilled nursing services, transitional care, and long term residential care specifically tailored to the
needs of elderly patients.
The LTCF is staffed by registered nurses, licensed vocational nurses, medications aides,
certified nurse aides, a director of nursing, three assistant directors of nursing, a facility
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administrator, rehabilitative services personnel, social workers, activities personnel, administrative
personnel, (receptionist, admissions coordinator, medical records clerk, and business office staff),
and other ancillary staff responsible for the day-to day functioning of the LTCFs (housekeeping and
nutrition services) (Table 2). Staffing needs are dictated by the current census. Nursing related
personnel are scheduled for 8-hour shifts (6:00 a.m. - 2:00 p.m., 2:00 p.m. - 10:00 p.m., and 10:00
p.m. - 6:00 a.m.) while the rest of the LTCF staff work from 09:00 a.m. to 5:00 p.m.
The Federal Nursing Home Reform Act (NHRA), as part of the Omnibus Budget
Reconciliation Act (OBRA) of 1987 does not provide specific nurse-to-resident staffing ratios for
registered nurses, licensed vocational nurses, or certified nurse aides as long as there is a registered
nurse on duty at least eight hours a day, seven days a week (this includes the director of nursing) for
facilities that have less than 60 residents), seven days a week and a licensed nurse (registered nurse
or licensed vocational nurse) on duty the rest of the time. There is no required minimum staffing for
CNAs (National Consumer Voice for Quality Long-Term Care, 2017).
From a financial standpoint, the facility administrator at the facility communicated that the
ideal staffing ratio for twenty-two patients is one registered nurse or one licensed vocational nurse
with a medication aid and a certified nurse aide. Input from the nurses at the facility revealed that
they are frequently understaffed and overworked, particularly on the weekends. They stated that the
nurse to patient ratio could be better given the high acuity level of the residents.
There are three physician group practices that deliver facility-based services to the LTCF.
The microsystem of interest are the patients assigned under the services of Dr. A. Dr. A. is a DNP
board certified family nurse practitioner who has been employed by one of the three physician
practices for approximately six months. The group practice is one of the nation’s leading providers
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Table 2
Type of employees in LTCF
_____________________________________________________________________________________
Nursing Staff
Number of Staff
LTCF Staff Description if Applicable
_____________________________________________________________________________________________
RNs
5
1 DON, 1 ADON, 3 staff RNs
_____________________________________________________________________________________________
LVNs
24
2 LVNs who are also ADONs and 2 LVNs
that Accomplishes Minimum Data (MDS)
full-time
_____________________________________________________________________________________________
CNAs
38
Full/part-time, and PRN
_____________________________________________________________________________________________
Med Aides
6
Full-time
_____________________________________________________________________________________________
Rehabilitation Services
_____________________________________________________________________________________________
Physical Therapy (PT)
9
5 PTs and 4 PT assistants
_____________________________________________________________________________________________
Occupational Therapy (OT)
6
1 OT and 5 certified OT assistants
_____________________________________________________________________________________________
Speech Therapy (ST)
2
1 ST and 1 ST assistant
_____________________________________________________________________________________________
Activities
2
1 activities director and 1 activities assistant
_____________________________________________________________________________________________
Administrative Services
_____________________________________________________________________________________________
Facility Administrator
1
_____________________________________________________________________________________________
Human Resources
1
_____________________________________________________________________________________________
Admissions Coordinator
1
_____________________________________________________________________________________________
Business Office
2
_____________________________________________________________________________________________
Medical Records
1
_____________________________________________________________________________________________
Ancillary Services
_____________________________________________________________________________________________
Receptionist
1
_____________________________________________________________________________________________
Social Worker
1
_____________________________________________________________________________________________
Housekeeping
2
_____________________________________________________________________________________________
Nutrition Services
3
1 registered dietician and 2 dietary aides
_____________________________________________________________________________________________

Note. All staff are hired by the facility
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of hospital medicine and other related facility-based services. Dr. A. is assigned to a total of three
LTCFs and is expected to visit skilled nursing care patients three times per week and long term care
residents every 60 days. This assignment is in addition to attending to acute issues that surface in the
long term care residents, on-call coverage two to three times per week as well as every other
weekend on-call coverage for her “pod” (which consists of a physician and two nurse practitioners).
Dr. A. has an assigned a monthly patient quota of 240 visits per month. Currently, she sees 180 to
200 patients per month.
Based on direct observation of the workflow at the LTCF, the facility was frequently shortstaffed, relied heavily on paraprofessional staff (licensed vocational nurse and medication aides), and
lacked a unit clerk at the nurse’s station, which may have alleviated the burden for licensed
personnel in answering phone calls, transcribing orders, and filing documentation. Lack of a unit
clerk contributed to a chaotic environment by not having permanent personnel responsible for
maintaining the accuracy and security of confidential health records. Laboratory, pharmaceutical,
and radiology services were provided by outside contractors.
The providers did not have dedicated office space at the LTCF which was an ongoing
practice issue. Unnecessary interruptions from patients, staff, and visitors were a frequent
occurrence. The facility did not have an electronic medical chart system. Dr. A disclosed that most
of her time was devoted to completing all necessary documentation by hand. There was an enormous
pressure to meet the 240 visits per month quota along with ensuring that billing and coding was
submitted in a timely manner for immediate reimbursement. Dr. A stated that the overwhelming
amount of paperwork and productivity expectations impeded her time and ability to make certain
that the recommended age appropriate T2DM guidelines for her group of patients were properly
executed.
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Leadership at the LTCF was unstable. The newly hired director of nursing who had been
there for over one month at the time of the assessment was terminated since she did not attend work
for two weeks. She did not notify anyone of her absence. Per staff report, this was the second
director of nursing in eight months. At the time of the needs assessment, the facility administrator
had only been in the position for over four months and ultimately resigned at the six-month mark. By
the time the project was implemented, an interim facility administrator was in place and a permanent
director of nursing had been hired.
The facility administrator conveyed that the facility accepts most insurances but Medicare
and Medicaid are the predominant payers that provide coverage for their residents. Medicare
reimburses at a rate of $475 per day, while Medicaid reimbursement is at a rate of $167 per day.
Private pay patients are also accepted at a rate of $4500 per month for semi-private rooms and $9000
per month for private lodging. The facility does accept patients pending Medicare or Medicaid
approval; but if funding falls through, the facility will absorb the financial loss. Services for the
residents such as food, medications, radiology or laboratory services are bundled into this fee.
Provider visits and off-site consultations are independently billed by the providers. Figure 2 for a
breakdown of the mentor’s patients according to payor source.
The clinical assessment data was collected using a personal interview involving the following
healthcare personnel: one Advanced Practice Registered Nurse (APRN), four registered nurses
(which includes one director of nursing, one assistant director of nursing, and two staff registered
nurses), and eight licensed vocational nurses. These personnel were purposefully selected for the
loosely structured interview since they were acquainted with the day-to-day care of the elderly
residents with T2DM with co-morbid conditions in the LTCF (target population). The participants
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were asked if they were aware of what the desirable HbA1c targets were for their population
(Appendix A). They were reassured that there was no right or wrong answer and that the

Types of Insurance at the LTCF
Pending

1

Private Pay

4

Medicaid

9

Medicare

2
0

1

2

3

4

5

6

7

8

9

10

Figure 2. Payer types at the LTCF. Of the 16 mentor patient charts reviewed, 9 patients were
Medicaid recipients, 4 were Private Pay, 2 were Medicare, and 1 was pending Medicare or Medicaid
funding.

purpose of the interview was to determine their baseline knowledge and identify any potential
deficiencies that may need to be corrected with education. Inquiry regarding the appropriate HbA1c
targets for the elderly effortlessly transitioned to the next question, which was: Are you familiar with
the diabetes treatment guidelines pertaining to periodic monitoring of complications associated with
T2DM? See Appendix A for the complete list of questions. Responses received from the nurses
indicated a general deficiency in adequate knowledge regarding the current guidelines pertaining to
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T2DM care of the target population. For example, the nurses were not able to specify the frequency
as to when routine blood draws associated with T2DM management need to be ordered.
Use of the key informant approach was the technique utilized in garnering more detailed
information from the APRN, director of nursing, and facility administrator. These people were
identified as the leaders, stakeholders, and key decision makers who were knowledgeable about the
policies and procedures of the facility. Key informants are valuable in the manner that they are able
to accurately identify priority needs and concerns regarding the care of the target population (Iowa
State University, 2017). A confidential discussion with the APRN revealed several barriers that
prevented her from achieving the best care possible for the target population such as ordering off-site
consultations for ophthalmology and podiatry services. Difficulties in ensuring routine surveillance
for the other complications associated with T2DM were also communicated.
The primary issue hindering the APRN from accomplishing this task was described as
“competing priorities”. Minimal information was garnered from the director of nursing at the facility
since that employee had been at the facility for just over one month. The facility administrator at the
facility was helpful in providing information about the regulations surrounding the management of
nursing home facilities and the billing/reimbursement practices for this predominantly Medicare
and/or Medicaid covered group.
An existing data approach was used to determine the deficiencies in the care of the target
population. A census list of the patients exclusively assigned to Dr. A’s services was obtained.
Recommendations to exclude patients admitted for long term acute care, hospice/palliative care,
rehabilitation services, and respite care was abided by since these patients were at the facility for a
short duration of time. A medical demographic sheet was created to record information about the
patient’s demographic variables, HbA1c results, and co-morbid conditions (Appendix B). This was
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later expanded to include information on the frequency of ophthalmology and podiatry visits and
routine laboratory values associated with T2DM care. As previously mentioned, the facility does not
have an electronic medical record system. Data was manually extracted from the charts. No patient
identifiable information was collected or recorded. The chart audit revealed that the top five
medical diagnoses were type 2 diabetes mellitus, coronary artery disease, dementia, chronic renal
failure and dementia. Anonymity of the patients was maintained using coded numbers; no names
were used.
The face-to-face interview with the APRN revealed that she was aware that the target HbA1c
should be above 7.0% for the target population but she was unable to provide details on the factors
that dictated the need for individualization. The APRN reported that HbA1c results on the chart were
taken at face value without further investigation of its concordance with the finger stick blood
glucose values. There are contributing factors that may cause a discordance with the HbA1c values
particularly for those patients that have conditions that impact the turnover of red blood cells such as
low hemoglobin/hematocrit values (causes for HbA1c to be lower), iron deficiency anemia (causes
HbA1c to be higher), or recent blood transfusions (HbA1c result is reflective of donor’s HbA1c
value). The HbA1c results has its limitations since it is an indirect measure of the average glycemic
control for the past three months. For these patients, the best indicator for glycemic variability are
the finger sticks (ADA, 2017a, p. 48). The value of the HbA1c needs to be reviewed in conjunction
with the glucometer readings (finger stick results) to evaluate appropriate diabetes management and
to determine if the frequency of the finger sticks is sufficient (ADA 2017a, p. 48).
The director of nursing at the facility was unsure of what the HbA1c targets were. The
response received was “I know it should be higher.” The assistant director of nursing and one
licensed vocational nurse stated that it should be between 4%-5%, while the seven licensed
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vocational nurses and two staff registered nurses openly acknowledged “I don’t know” adding that if
the results fell within the recommended ranges specified on the laboratory results sheet the patient’s
HbA1c was considered “under control.”
Medical records were reviewed to obtain further data about the microsystem. Sixteen out of
thirty-seven charts reviewed at the facility were eligible for inclusion (65 years of age and above
with T2DM and not admitted for hospice/palliative, skilled nursing services, rehabilitation, acute
care, or respite care). The median age of the included patients was 75 years old (67-94 years old)
(Figure 3) and consisting of eleven males and five females. Age distribution was broken down as

Age

33%

39%

28%

65-75

76-85

86-95

Figure 3. Age distribution of participants. This figure illustrates the age distribution of project
participants.

follows: 65-75, 76-85, and 86-95 years of age which corresponded to seven, five, and four patients
respectively).
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The median HbA1c level for these patients was calculated at 6.7% (range was from 5.1%10.5%). HbA1c ranges were established at <7.0%, 7.0%-7.5%, 7.5%-80%, and >8.0; corresponding
to 11, 2, 1, and 2 patients). Three of the medical records did not have the HbA1c test ordered. The
HbA1cs were generally lower than the recommended individualized target for this population
(Figure 4).

HbA1c

13%
6%
12%
69%

<7.0

7.0-7.5

7.5-8.0

>8.0

Figure 4. HbA1c levels of 16 project patients. This figure illustrates the HbA1c breakdown
percentage of 16 patients.

The 16 patient records included for evaluation in this project had more than one co-morbid
condition (see figure 5). Dementia (12 out of 16 patients) and the presence of macrovascular
complications such as cerebrovascular accidents/transient ischemic attack (nine patients), coronary
artery disease (10 patients), congestive heart failure (three patients), and peripheral vascular disease
(three patients) were the leading co-morbidities that were identified. Eight out of 16 patients at the
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LTCF had a documented diagnosis of CKD with two patients receiving hemodialysis three times per
week (Figure 5).

Co-Morbid Conditions Present at LTCF
14
12
10
8
6
4
2
0

Figure 5. LTCF co-morbid conditions. This figure depicts the co-morbid conditions present amongst
the 16 project patients.

Pertaining to routine T2DM care, the APRN indicated that since she has been there for six
months, has not ordered any ophthalmology or podiatry referrals for any of the patients. Reportedly,
she was informed by the APRN who oriented her that off-site referrals for these services were not
seen as necessary since the patients were “on their way out.” She later acknowledged that the leading
factor for not ordering the referrals was dependent on allowed services specific to each resident’s
healthcare insurance carrier. For example, Medicaid will pay for an annual optometry visit for
eyeglasses (coverage for this service is optional) but not for a dilated diabetic retinal exam
(Medicaid.gov, 2017). Of the 16 charts reviewed, only four patients had ophthalmology visits for

INDIVIDUALIZED GLYCEMIC TARGETS FOR THE ELDERLY

27

glaucoma treatment and not for an annual diabetic retinal exam. The remainder of the charts (12) did
not have ophthalmology visits recorded in the progress notes.
Among the 16 patient records, only five podiatry visits were noted on the charts and four of
these were ordered at the request of the patient or the patient’s family. The director of nursing
disclosed that there is a podiatrist that comes to the facility but only to address specific problems
and/or a request made by the staff. Once a patient is seen, the podiatrist becomes a listed service
provider for the patient for routine checks provided there is a predisposing condition that justifies the
visit. For Medicaid recipients, podiatry services may not be covered, but Medicare beneficiaries may
be eligible for examination and treatment of the feet every six months when there is a documented
diagnosis of diabetic sensory neuropathy and loss of protective sensation (Department of Health and
Human Services [DHHS], 2010). Otherwise, routine T2DM care involving retinal examinations and
foot checks were not done on the patients seen by the APRN.
The rates of compliance pertaining to routine laboratory checks for HbA1c, albuminuria, and
renal function studies were low. Current ADA Standards of Medical Care in Diabetes stipulate
quarterly HbA1c checks in patients who are not meeting glycemic targets and annual assessment of
urinary albumin to creatinine ratio and renal function tests for diabetic kidney disease surveillance
(ADA, 2017a). For the 16 patient records reviewed, HbA1c levels were ordered at a frequency of
every month to six months. There were no microalbuminuria studies found on any of the charts;
while renal function studies were ordered every other day, to weekly, or five months later. Dr. A. has
acknowledged that the patient load demand, increased patient acuity, and expectations set by her
employer play a critical factor in her inability to provide appropriately individualized T2DM care for
the elderly patients assigned to her “pod”.
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Strengths identified at the LTCF were: (1) the APRN awareness about the issues restricting
proper T2DM care for her assigned patients; (2) committed APRN receptiveness to improving
T2DM care for her group of patients; (3) assistant director of nursing amenable to staff education
and dedicated to residents’ needs; (4) strong commitment by facility administrator to improve care
and quality of life for residents, and (5) demonstration of staff willingness to work together to
achieve a common goal.
Weaknesses identified included: (1) APRN assignment to three nursing homes limited the
provider’s time to ensure individualized T2DM care; (2) APRN decisions to order ophthalmology or
podiatry referrals influenced by management; (3) healthcare staff’s (registered nurses and licensed
vocational nurses) knowledge deficit regarding evidenced-based T2DM care guidelines; (4) the
need to modernize information system technology (i.e. electronic records); (5) facility administrator
views healthcare from finance perspective – business demands of healthcare viewed as priority
issue; (6) fragmentation of documentation due to contracted laboratory services; (7) unstable LTCF
leadership; and (8) rapid staff turnover rate. Identification of the strengths and weaknesses available
for certain opportunities and threats for the QI project implementation are illustrated in Table 3.
Significance of the Problem
Use of the Dartmouth Clinical Microsystem Assessment tool (Dartmouth College, 2008)
unmasked numerous deficiencies at the LTCF. It revealed that there was poor communication and
teamwork amongst the staff, potential understaffing, rapid staff turnover, unstable leadership, the
absence of a centralized electronic medical record and most importantly, non-adherence to ADA
recommendations for certain patients. These identified problems significantly impact the
individualized care of older adults with diabetes who reside in LTCFs.
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Table 3
Opportunities and threats for QI project implementation
_____________________________________________________________________________________________
Opportunities
Threats
_____________________________________________________________________________________________
* healthcare staff is given the leadership role
* increasing health care costs resulting in falling
to address geriatric health issues
revenue for the facility
* there is potential to formally coordinate how
* reduced funding from Medicare & Medicaid
routine T2DM care services are rendered
* misinformation about T2DM care for the
* improve patient safety through individualized
elderly
T2DM care for the elderly
* lack of electronic medical records system
* collaborative effort to address the deficiencies
* too much management intervention
ensure comprehensive T2DM care
regarding limiting costs
* increased awareness of evidence-based practice
* limited reimbursement for nursing homes
* collaborative health improvement effort addressing
* older and sicker patients
routine T2DM care may lower complications and
* information overload for the staff
hospitalization rates
* standardization will prevent duplication of services
_____________________________________________________________________________________________

Note. Sample strengths and weaknesses for the implementation of the QI project.

Dimensions addressed during the implementation of the quality improvement (QI) program
included: (1) the healthcare team’s lack of familiarity with the modified HbA1c targets for the
elderly proposed by the most current ADA guidelines (Table 4); (2) the types of co- morbid
conditions prevalent in the target population, the number of elderly patients who do not have
individualized HbA1c targets that take into consideration their age and co-morbid conditions; and
(3) ensuring that monitoring of conditions and complications associated with T2DM.
Hausken and Graue (2012) note the glaring discrepancies within the ADA’s
recommendations versus the true-to-life care of institutionalized elderly patients with T2DM patients
in poor health conditions. High quality evidenced-based care is lacking in the treatment and care of
this population due to the inadequate training of health care staff driven by the rising number of
diabetes cases among those age 65and older admitted to LTCFs with complex medical needs and
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complicated treatment regimens (Hausken & Graue, 2012). Similarly, Smide and Nygren (2013)
identified discernible gaps in levels of diabetes knowledge when LTCFs health care workers were
presented with a case study regarding the proper care of an elderly patient with T2DM.
Table 4
HbA1c targets in older adults with T2DM
_____________________________________________________________________________________________
Patient characteristic/health
Rationale
Reasonable HbA1c target goal
status
_____________________________________________________________________________________________
Healthy (few con-existing chronic
Longer remaining
<7.5% (58 mmol/mol)
illnesses, intact cognitive and
life expectancy
functional status
_____________________________________________________________________________________________
Complex/intermediate (multiple
Intermediate remaining
<8.0% (64 mmol/mol)
coexisting chronic illnesses or 2+
life expectancy, high
instrumental activities of daily
treatment burden,
living impairments or mild to
hypoglycemia
moderate cognitive impairment
vulnerability, fall risk
_____________________________________________________________________________________________
Very complex/poor health (LTC or
Limited remaining life
<8.5% (69 mmol/mol)
end-stage chronic illnesses or
expectancy makes benefit
moderate to severe cognitive
uncertain
impairment or 2+ activities of daily
living dependencies
_____________________________________________________________________________________________

Note. Framework for considering treatment goals for glycemia. Adapted from “Standards of medical
care in diabetes – 2017,” by ADA, 2017, Diabetes Care, 40(1), p. S101. Copyright 2017 by the
American Diabetes Association.

Individualization of HbA1c targets in the elderly with T2DM and co-morbidities is of
paramount importance because inappropriately tight glycemic targets can predispose this
compromised group to a myriad of preventable complications such as diabetic retinopathy, diabetic
kidney disease, diabetic peripheral neuropathy, and foot ulcers (ADA, 2017a). Routine screening for
CKD and diabetic retinopathy; the two major microvascular complications associated with T2DM
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needs to be emphasized. Urine albumin to creatinine ratio (UACr) and declines in glomerular
filtration rate (eGFR) are the best clinical indicators of renal function status (ADA, 2017a). A study
by Rodriguez-Poncelas et al. (2016) showed that CKD, elevated UACr and/or presence of declining
GFR was associated with the development and progression of diabetic retinopathy. Benetos et al.
(2013) note that a comprehensive ophthalmological examination that incorporates visual acuity,
dilated-eye slit-lamp examination, and retinography is critical in the timely identification and
treatment of diabetic retinopathy to minimize visual loss.
Purpose of the Project
The primary aim of the project was to improve the delivery of routine T2DM care in the
elderly with comorbid conditions at one LTCF by having the APRN increase her knowledge of and
follow an order set following the 2017 ADA Standards of Medical Care in Diabetes guidelines and
increasing nursing staff’s knowledge of diabetes care for this population. A change in the provider’s
ordering practice using a checklist sheet and standardized order sheet was intended to prevent and/or
delay the progression of diabetes-related complications, to ensure safer care, to preserve functional
abilities, to promote independence, and to maintain or improve quality of life for this susceptible
population (ADA, 2017a).
The secondary aim of the project was to educate the registered nurses, and licensed
vocational nurses regarding applicable 2017 ADA Standards of Medical Care in Diabetes evidencebased guidelines related to the treatment of elderly patients with T2DM with co-morbid conditions.
Through the educational one-on-one in-services, it was communicated that tight glycemic control is
not applicable for the elderly with complex health conditions and that although major goal of tight
glycemic targets is to prevent long term complications, it is more pertinent for healthy and younger
older adults (<65 years old) who have an additional life expectancy of at least 10 more years.
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Review of Literature Evidence
Question Guiding Inquiry (PICOT)
Does the implementation of an evidenced-based diabetes toolkit improve the individualization
of HbA1c targets and routine T2DM care in elderly patients with T2DM complicated by co-morbid
conditions and functional limitations who reside in LTCF?
Benchmarking
In healthcare, benchmarking is the process of comparing an organization’s key performance
measures against nationally-recognized best practices, targets, or goals (Kay, 2007). For this quality
improvement project, the 2017 ADA Standards of Medical Care in Diabetes were used as the
reference point for the evidence-based delivery of care for the target group. For the last 25 years, the
ADA has steadfastly developed and distributed diabetes care standards, guidelines, and other related
documents. Healthcare professionals tasked with the care of patients with diabetes have come to
view the ADA Standards of Medical Care in Diabetes, position statements, and scientific statements
as the blueprint for clinical decision making (ADA, 2017a).
Methodology (Search Strategy)
A literature search of relevant literature was performed from January 2015 to September
2017. Searches were made in the following databases: CINAHL, EBSCOHost, Medline, NCBI,
PubMed, PubMed Central, and ScienceDirect. Search terms included “American Diabetes
Association guidelines,” “co-morbidities,” “diabetes,” “diabetes related knowledge,” “diabetes
management,” “elderly,” “evidenced-based diabetes management,” “geriatric,” “gerontology,”
“individualized care,” “long term care,” “modified HbA1c target,” “nursing home,” “older adults,”
“older people,” “routine diabetes care,” and “type 2 diabetes.” The search terms were used for all
fields (including title, abstract, keywords and full text). Searches were limited to English-language
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peer-reviewed journals published in the last five years. The initial literature search yielded 22,098
peer reviewed articles on the topic. The final number of articles considered was 33. Other materials
referenced were association reports, government websites, and society transactions.
Critique and Synthesis of Research Findings
To establish the evidence base for the recommended appropriate glucose control in the
elderly, 10 intervention articles published in English were examined. The studies predominantly
involved elderly adults with T2DM using various glucose lowering agents (GLA) to achieve
intensive glucose control. Three recurring themes were identified from the selected articles (Table
5). All 10 articles investigated the effect of advancing age, co-morbid conditions, and what role the
type of GLA therapy selected contributes to the incidence of hypoglycemic events.
Table 5
Identified themes from different evidence sites
Theme
Survival rates, role of various GLA
therapies in inciting hypoglycemia,
associated T2DM complications, and
mortality rates in the elderly with comorbid conditions.
Guideline implementation for glycemic
control in the elderly with T2DM.

Authors
Claesen et al. (2016); Fang et al. (2013);
Huang et al. (2014); Lee et al. (2011); Lipska
et al. (2015); Pilotto et al. (2014); Roumie et
al. (2016); Tseng et al. (2014); Vijan et al.
(2014); and Yau et al. (2012).
Lee et al. (2011); Yau et al. (2012); Tseng et
al. (2014); Vijan et al. (2014); and Yau et al.
(2012).
Risks and benefits of intensive glycemic
Fang et al. (2013); Lee et al. (2011); Lipska et
control in the elderly and its outcomes.
al. (2015); Pilotto et al. (2014); Roumie et al.
(2016); Tseng et al. (2014); Vijan et al.
(2014); and Yau et al. (2012).
Note. Articles describing factors contributing to the incidence of hypoglycemic events.
Caution regarding the use of sulfonylurea with or without insulin in the elderly with comorbid conditions was emphasized due to the following issues associated with aging: decreases in
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hepatic and renal function affecting drug metabolism and clearance, dampened autonomic response
to hypoglycemia, alterations in the presentation of symptoms, distortion in glycemic margins,
heightened hypoglycemia unawareness, existence of multiple co-morbidities, and rampant
polypharmacy (Jafari & Britton, 2015). Of significance is presentation of cardiovascular (CV)
complications associated with T2DM (myocardial infarction and ischemic stroke) as the co-morbid
condition that places elderly persons at highest risk for hypoglycemic events. Intensive glycemic
control predisposes the elderly to fatal cardiac arrhythmias due to the prolongation of the QT interval
brought about by catecholamine release as a response to hypoglycemia (Jafari & Britton, 2015).
Recommendations to adhere to the guidelines relaxing HbA1c targets based on life
expectancy, functional, status, and patient preference were discussed in 5 out of the 10 articles
(Claesen et al., 2016; Huang et al., 2014; Lipska et al., 2015; Pilotto et al., 2014; & Vijan et al.,
2014). The consensus in 8 out of the 10 articles that the target HbA1c need to be individualized in
the elderly population due to their compromised health status (Huang et al., 2014; Lee et al., 2011;
Lipska et al., 2015; Pilotto et al., 2014; Roumie et al., 2016; Tseng, Soroka, Maney, Aron, &
Pogach, 2014; Vijan et al., 2014; & Yau et al., 2012). Treatment goals for the elderly with T2DM
need to be focused on preventing poor outcomes, maintaining quality of life, preventing injuries such
as falls, and guaranteeing continued independence if possible (Pilotto et al., 2014; & Yau et al.,
2012).
Six out of 10 articles selected were retrospective studies (Fang et al., 2013; Huang et al.,
2014; Lipska et al., 2015; Pilotto et al., 2014; Roumie et al., 2016; & Tseng et al., 2014) that
involved data extraction from healthcare expenditure records (National Alliance of Christian
Mutualities, The Kaiser Permanente Northern California Diabetes Registry, and Veterans Health
Administration Database) or derived from other large studies (National Health and Nutrition
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Examination Survey and Metabolic Study). Huang (2016) noted that older patients with T2DM have
been consistently excluded from large scale prospective clinical diabetes trials due to the inherent
difficulties associated with their management. He cited two trials that attempted to accomplish this
difficult task. The Action to Control Cardiovascular Risk in Diabetes (ACCORD) attempted to
investigate the effect of intensive glycemic management in patients over the age of 80 but the high
rates of hypoglycemic events that occurred after the participants were randomized into the
intervention arms led to the revision of the study protocol to exclude patients over 80 years old
(Huang, 2016). Likewise, researchers in the Japan Elderly Diabetes Intervention trial involving
1,173 patients were unable to evaluate a multiple risk factor intervention in patients aged 65-85 years
due to treatment related hypoglycemic events in older patients (Huang, 2016). The remainder of the
articles were small scale prospective studies (Fang et al., 2013; Lee et al., 2011; & Yau et al., 2012)
and a simulation study (Vijan et al., 2014). Although small and simulated, it provided substantial
information on other selected outcomes such as micro/macrovascular complications, functional
outcomes, and quality of life issues. Overall, all 10 articles selected had the goal of providing
targeted care management in the elderly. Care for the older patient with T2DM revolves around
weighing the risks and benefits of tight glycemic control in this vulnerable group (Huang et al.,
2014; Lee et al., 2011; Lipska et al., 2015; Roumie et al., 2016; Tseng et al., 2014; Vijan et al., 2014;
& Yau et al., 2012).
Limitations (Literature Gaps)
Kirkman et al. (2012) asserted that despite the pervasiveness of diabetes in older adults aged
65 years and older, particularly those with co-morbid conditions and functional limitations, they
have mostly been excluded from randomized controlled trials due to the complexity in their health
conditions. Benetos (2013) noted that the overall dearth of evidence-based guidelines specific to the
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management of diabetes in the elderly who reside in nursing homes is due to the heterogeneity of
this population with regards to comorbidities, polymedication, and frailty. Anderson’s (2014)
national audit of 2,043 nursing homes reinforced that significant gaps in the care of these residents
existed. Specifically, 63% of the homes audited lacked a representative accountable for diabetes
management and 33% of homes lacked direct access to training materials supportive of diabetes care
(Anderson, 2014). Findings from the Institute of Diabetes in Older people has created a push to
provide better education and training for nurses and stricter governance to providing high-quality
evidence-based care.
Methodology
Design (Intervention Strategy)
This two-pronged quality improvement project aimed to increase the APRN’s (provider)
knowledge and utilization of the ADA Standards of Medical Care in Diabetes – 2017 guidelines and
to educate staff nurses on current evidence-based practice for LTCF residents with diabetes. For the
APRN provider, a one-on-one review on the 2017 ADA Standards of Medical Care in Diabetes
pertaining to the importance of adherence to the recommended diagnostic and therapeutic actions in
the prevention and management of diabetes complications for the target population was
accomplished on June 5, 2017. Emphasis was placed on the modified HbA1c targets for elderly
patients with T2DM with co-morbid conditions and functional limitations. Recommendations to
implement an individualized HbA1c target based on the risk to benefit ratio was presented via a
handout (Appendix C). There was an emphasis that lower HbA1c goals for the target population was
not necessarily better and aggressive control in patients with advanced diabetes and heart disease
was not warranted.
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The strengths and limitations of the HbA1c test as an accurate representation of the patient’s
average glucose was explored with the provider. It was highlighted that the HbA1c is not a perfect
test. Examples of conditions that can cause a discordance between the HbA1c and mean glycemia
were presented (Appendix D). The main talking point here was that hemoglobin and red blood cell
pathologies renders the accuracy of the HbA1c as a potentially unreliable biomarker for glycemic
control (ADA, 2017a, p. 50). Lastly, the routine T2DM checklist and standardized order sheet
(Appendices E & F) developed with the input of the provider was incorporated into the charts of
those patients who met the inclusion criteria to remind the provider when to order the recommended
tests/procedures.
Exclusively for the provider, a pocket sized printed HbA1c glucose value converter was
presented (Appendix G). Included in it were the conditions that can falsely lower HbA1c results,
particularly clinical conditions that can shorten erythrocyte life span or decrease mean erythrocyte
age. The primary purpose of the information sheet was to alert the APRN provider that HbA1c
results may not accurately reflect glycemic control when clinical conditions that affect erythrocyte
survival are present (ADA, 2017a). The expectation was that the provider would pursue
investigation of those conditions that may cause discrepancies between HbA1c results and daily
glucose values to enable the provision of timely patient interventions. With regards to
individualization of HbA1c targets, the provider was encouraged to annotate on the progress notes
the appropriately individualized HbA1c for the target population based on the ADA 2017 Standards
of Medical Care in Diabetes guidelines (Table 1). Annotation of the modified HbA1c target on each
patient’s chart may ensure that optimal care is delivered since this serves as form of communication
for other providers who may be responsible for the care of the patient in other circumstances.
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Education for the APRN was planned according to Dayal and Alvarez’s (2015) attestation
that standardized order sets facilitated improved compliance with recommended evidenced-based
standards of care while simultaneously ensuring appropriate resource utilization and delivery of costeffective quality care. To improve compliance with the required routine T2DM care, a concise
checklist and standardized order sheet was adapted from the 2017 ADA Standards of Medical Care
in Diabetes and added into the chart to avoid oversight of the crucial elements in the prevention of
complications associated with T2DM. The purpose of the checklist was to improve efficiency by
prompting the healthcare staff and provider when certain screenings and assessments were due to be
ordered (Appendix E&F) and establish that none of the required routine care for T2DM was
overlooked. Although it was not a part of the QI implementation project, information regarding
annual lipid checks and the routine required immunization checks were included in the checklist and
standardized order sheet per discussion with the project coordinator to ensure that the other 2017
ADA Standards of Medical Care in Diabetes could be met.
For the nursing staff, the plan for the intervention strategy was to provide a one-one-one inservice program that educated the healthcare staff on the most current evidenced-based guidelines
promulgated by the ADA in 2017. Specifically, the education intervention was intended to improve
compliance with routine T2DM care for the target population. With permission from the LTCF
management, a one-one-one in-service with the use of informational handouts was delivered in midJune 2017 at a time that was convenient for the RNs/LVNs. The plan was to educate 80% of the
nurses (23 out of 29) on all three shifts. The one-on-one in-service was conducted in a private
conference room free of interruptions. The in-service provided a brief yet concise presentation of the
most current evidence-based guidelines regarding the appropriate care and importance of
individualized HbA1c targets in elderly patients with T2DM complicated by complex conditions
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(Appendix C, D, & L). A checklist (Appendix E) and simplified standardized order sheet (Appendix
F) was distributed to the 13 participants. Its potential value in improving the care of the target
population was highlighted.
Setting and Sample Plan
The location of the QI program implementation project was a LTCF located in southwest
Texas. Due to staff time constraints, the sampling strategy chosen for the education in-service was a
non-probability convenience sampling. This sampling plan allowed for the evaluation of the
effectiveness of the in-service education in a relatively fast and inexpensive manner (Lund Research
Limited, 2012). For the patient medical record audit, the sampling strategy chosen was the nonprobability purposive sampling method. The aim of the project was to evaluate data from a
homogeneous sample, that is, a group of elderly patients 65 years and older with T2DM and comorbidities who resided in a LTCF. A homogeneous sampling strategy was deemed appropriate for
this project since the PICOT question that was addressed specifically targeted the attributes of the
group of interest (Lund Research Limited, 2012).
Stakeholder Involvement
A stakeholder is anybody who can affect or is affected by an organization, strategy or project
(Morphy, 2017). Involvement of the stakeholder, whether an individual or a group is crucial in
achieving improved outcomes for the target group. For the LTCF, the stakeholders were the APRN
provider, management, healthcare staff, and patients. The APRN provider was supportive in the
development and planning of the QI project. Dr. A. provided substantial input on how to develop the
standardized orders to ensure that the best outcomes were achieved for the patients. Likewise,
support from management was obtained providing that it would not interfere with the healthcare
staff’s workflow and not cost the facility undue overtime costs. A suggestion from the facility
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administrator was to conduct the in-service during the LTFC’s planned monthly staff meeting.
Ultimately, this strategy was not feasible due to an unplanned state inspection during the week the
in-service was planned. Instead, the registered nurses and licensed vocational nurses were
approached on a one-on-one basis at a time that was convenient for them. Interest by the healthcare
staff in the QI project was shown by their desire to learn the current evidenced-based guidelines
regarding the appropriate care of the target population during the microsystem needs assessment.
Nurses specifically requested an in-service about the topic. Although the patients were not directly
involved in the QI project, the outcome of the process and results of the effort could have a
significant impact in their care. It was essential that Dr. A., the LTCF’s management, and its staff
were actively involved in the quality improvement program and intervention. Education, checklists,
and standardized order sheets that were specifically designed in the care of the target population
provided an increased opportunity for positive for the target population.
IRB Considerations
The process of obtaining an informed consent from the nurses or patients was not necessary
as no hands-on patient healthcare interventions was performed. The proposed project plan was a QI
strategy and did not involve direct patient care. Chart audits were kept confidential with no
identifying information recorded. The records were stored securely in a locked file cabinet in
compliance with the LTCF, university, and federal guidelines pertaining to the protection and
confidentiality of the participants’ identifiable information as mandated by the Health Insurance
Portability and Accountability Act of 1996 (HIPAA). University of the Incarnate Word IRB exempt
status approval was obtained, as well as a letter of support from the LTCF in lieu of IRB approval
due to the facility’s lack of an established IRB. Additionally, a letter of support for the completion of
the project was obtained from the LTCF.
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Evaluation Model
The New World Kirkpatrick Model (Kirkpatrick Partners, 2017) was the evaluation model
selected for the implementation of the quality improvement program at the LTCF. It is the updated
version of Kirkpatrick’s original four levels of training evaluation. A brief explanation of the
updated Kirkpatrick model is as follows:
1. Level I: Reaction. This level seeks to determine how much the participants are actively
involved in the learning process and what their contributions are into the learning
experience (engagement). It includes and inquiry regarding the pertinence of the training
learned on the job (relevance) (Kirkpatrick Partners, 2017).
2. Level II: Learning. This level measures the efficacy of the training and if the objectives
were accomplished based on five criteria: knowledge (“I know it”), skill (“I can do it right
now”), attitude (“I believe this will be worthwhile to do on the job”), confidence (“I think I
can do it on the job”), and commitment (“I intend to do it on the job”).
3. Level III: Behavior. This level evaluates the participant’s on-the-job use of the training
they received and incorporates factors (processes and systems) that strengthen, facilitate,
and positively reward performance of the crucial behaviors required to accomplish the job
(required drivers).
4. Level 4: Results. This level examines the tangible outcomes of the training and the
presence of short-term indicators that ensure that crucial elements in performance of the job
are consistently being applied to achieve the desired outcomes.
Kirkpatrick’s New World Evaluation model is beneficial in the methodical discovery of the
quality improvement’s (QI) value, quality, and significance based on a set of established criteria.
Evaluation of the Kirkpatrick evaluation model was considered throughout the design, development,
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and implementation of the QI project and brought to light problems that existed within the
organization. For example, the nurses were not aware of the current ADA guidelines pertaining to
the care of the elderly who reside in nursing homes. This information enabled the clarification and
refinement of those issues along the way. The suitability of the Kirkpatrick evaluation model in the
evaluation of the education in-service and T2DM routine checklist served as an unbiased measure of
the projects efficacy at each of the essential levels (Kirkpatrick Partners, 2017). It was identified as
the most appropriate evaluation model for the program implementation since the effectiveness of the
training program needed to be measured.

Objectives and Timeline
I.

By June 15, 2017, 100% of the provider (one provider) and 80% of the RNs/LVNs (23
out of 29) at the LTCF will:
a) Able to identify the current guidelines that exists for treating diabetes in
elderly patients following a one-on-one evidence-based educational in-service
presentation.
b) Able to identify the issues that need to be considered in individualizing
treatment recommendations for elderly patients.
c) Be familiarized and proficient with the use of the routine T2DM checklist and
standardized order sheet for T2DM routine care.

II.

By July 30, 2017, after implementation of the educational in-service and T2DM
routine checklist, the APRN provider will:
a) Improve the individualization of HbA1c targets in elderly patients with T2DM
complicated by complex medical conditions and functional limitations.
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b) Use the standardized order sheet that delineates the recommended test/procedures
for routine T2DM care on a consistent basis.
c) Pursue investigation of underlying conditions that may cause discordance
between the HbA1c and finger stick glucose values.
III.

By July 30, 2017, after implementation of the educational in-service and T2DM
routine checklist, 80% of the healthcare staff will:
a) Recognize the importance of routine T2DM care in the prevention/delay of
diabetes related complications.
b) Use the routine T2DM checklist consistently in elderly patients with T2DM
complicated by complex medical conditions and functional limitations.

IV.

By September 30, 2017, 80% of the elderly residents at the LTCFs with T2DM
complicated by co-morbidities and functional limitations will:
a) Have appropriately individualized HbA1c targets.
b) Have routine T2DM tests/care ordered according to the recommendations set
forth by the 2017 ADA Standards of Medical Care.

Evaluation Plan
The evaluation tool for the QI project were derived from the 2017 ADA Standards of
Medical Care in Diabetes and were adapted to fit the specific needs of the LTCF. The tools
(Appendix H & I) have not been tested for reliability and validity but have been formulated by
leading authorities in the field of endocrinology (ADA, 2017a). The information used to adapt the
questionnaire for the nurses and the checklist were free of charge and easily accessible online;
therefore, free of copyright restrictions regarding its use and duplication. To evaluate the impact of
the nursing educational program implementation, a pre- and post-test questionnaire was administered
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to those nurses who took part in the in-service (Appendix H). The pre- and post-test served as a
direct evaluation of the participants’ learning and it quantified the extent of the participant’s baseline
knowledge about the topic before the presentation and assessed the amount of learning achieved
thereafter (Boston University, n.d.).
Data Analysis Plan
A checklist was developed (Appendix J) to guide the formal post-intervention medical record
audit. The purpose of the chart audit was to systematically determine the outcomes of the QI
program implementation (Duke University, 2016). A baseline and post QI project implementation
chart audit was performed. Twenty-two charts that met the following criteria were included in the
post-intervention audit: Patients 65 years of age and above with T2DM and not admitted for
hospice/palliative care, skilled nursing services, rehabilitation services, acute care, or respite care
were included. The following information was collected by August 1, 2017 and evaluated by
September 15, 2017 to determine the effectiveness of the QI project:
1) Routine T2DM laboratory tests (HbA1c, urine albumin to creatinine ratio, serum
creatinine and GFR) ordered per the 2017 ADA Standards in Medical Care in
Diabetes guidelines.
2) Routine T2DM physical exams (eye exam and foot exam) ordered per the
guideline recommendations.
3) Individualized HbA1c targets set for the target population and were they
annotated on the progress notes.
4) Clinical conditions contributing to discrepancies on HbA1c results and
finger sticks further investigated?
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Data from the pre/post-test questionnaires (Appendix H), program feedback evaluation
(Appendix I), and chart audits (Appendix J) were collected. To analyze the results of the pre/posttest questionnaires and as a measure of the outcomes of the nursing education in-service, the number
of correct answers were totaled and divided by the total number of questions. Then a mean score was
calculated and pre- and post-test results were compared. Results from the questionnaires remained
anonymous. A code number was assigned to each nurse’s questionnaire so that pre- and posteducation questionnaires could be matched for statistical testing. Nurses did not sign their names to
the questionnaires. The timeline for project completion is depicted in a Gantt chart (Appendix K).
Results
Analysis of Data
The 22 medical records that met the inclusion criteria for the QI project and were reviewed
for analysis of project objectives included 13 females and nine males (Table 6). The age composition
of the residents and racial makeup are included in the table. The racial composition was
predominantly Hispanic 82% (n=18). The clinical characteristics of the sample were burdened with
multiple co-morbidities that significantly impacted their functional status. For the whole patient
population (all age groups), the top five common co-morbidities were chronic kidney disease/end
stage renal disease (77%), dementia (64%), coronary artery disease (77%), cerebrovascular accident
(45%), and peripheral vascular disease (9%). The mean HbA1c was at 7% (SD = 1.38) minus one
that was identified as missing during the pre-implementation chart review. Functional status level
specifying the patient’s ability to manage activities of daily living such as basic self-care eating,
bathing, dressing, toileting, transferring, and continence) and instrumental activities of living
(managing money, shopping, telephone use, travel in community, housekeeping, meal preparation,
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Table 6
Characteristics of residents with diabetes selected for the QI project.
_____________________________________________________________________________________________
Categories
Number of Residents
_____________________________________________________________________________________________
Gender
Male
9
Female
13
_____________________________________________________________________________________________
Age
65-75
8
76-85
7
86-95
5
>96
2
_____________________________________________________________________________________________
Race
Hispanic
18
Caucasian
4
_____________________________________________________________________________________________
Co-morbidities
CKD/ESRD
17
Dementia
14
Coronary artery disease
14
Cerebrovascular accident
10
Peripheral vascular disease
2
_____________________________________________________________________________________________
HbA1c
<7.0
12
7.0-7.5
2
7.5-8.0
3
>8.0
4
Missing
1
_____________________________________________________________________________________________
Functional Status
Dependent
20
Partially dependent
2
Independent
0
_____________________________________________________________________________________________
Healthcare carrier
Medicaid
19
Medicare
1
Private pay
2
_____________________________________________________________________________________________

Note. This table depicts characteristics of the 21 residents included in this study.
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and taking medications as prescribed) were collected from the intake sheets (University of Michigan
Medical School, 2003). The predominant payer type for healthcare coverage was Medicaid (86%).
Results of Findings Corresponding to Objectives
For the first objective, the target was to provide one-on-one educational in-services to the
APRN provider and 80% (23 out of 29) of the nurses. This goal was achieved with the provider
(100%) but only 13 (45%) of the nurses. Unforeseen circumstances such as rapid staff turnover,
short staffing, high patient acuity, patient emergencies, and unannounced state inspections hampered
nursing participation. The nurses were approached for the in-services at a time that was convenient
for them without interfering or compromising patient care as requested per the administration. A pretest consisting of 10 questions was administered at week one to determine baseline knowledge
followed by a post-test at week two and week four. The respondents consisted of an APRN, three
RNs, and nine LVNs.
Results of the pre-assessment showed a significant deficiency in the diabetes-related
knowledge regarding the care of LTCF residents with T2DM. The top three missed questions from
the pre-test assessment (Table 7) were regarding individualization of HbA1c targets in the elderly
(question # 6 and #7) and the recommended HbA1c goal for most patients set forth by the ADA
(question #2). At post-test #1, results almost mirrored that of the pre-test; with the top three missed
questions as being the recommended HbA1c goal for most patients by the ADA (question #2) as the
most missed, followed as a tie by individualization of HbA1c targets in the elderly (question #6) and
priority of care for older adults (question #10). By post-test #2, the top three missed questions were
regarding individualization of HbA1c targets (question #7), conditions that increase hypoglycemia in
older adults (question #8), followed as a tie by question #6 (HbA1c individualization) and question #
3 (mortality risk for elderly patients with non-individualized HbA1c targets). Overall, results of the
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total scores indicated a significant improvement in diabetes-related knowledge specific to the care of
the target population (Figure 6). The differences in scores by type of nurse is illustrated in Figure 7.
Table 7
Most missed questions from the pre/post-test Questionnaires
Type
Question Missed
_____________________________________________________________________________________________
Question #6: What would be a reasonable HbA1c goal for a 72-year-old woman with a
Complex health status, blood pressure of 140/90 mmHG, and fasting glucose of 100 to
150 mg/dL?
Pre-test
Question #7: What would be a reasonable HbA1c target for an older patient with
history of recurrent hypoglycemia, limited life expectancy, multiple co-morbid
conditions, advance chronic kidney disease, and history of strokes?
Question #2: The HbA1c goal for most patients recommended by the ADA should be at?
_____________________________________________________________________________________________
Question #2: The HbA1c goal for most patients recommended by the ADA should be at?
Question #6: What would be a reasonable HbA1c goal for a 72-year-old woman with a
Post-test #1
Complex health status, blood pressure of 140/90 mmHG, and fasting glucose of 100 to
150 mg/dL?
Question #10: The priority or care for older adults with T2DM is the avoidance and
prevention of?
_____________________________________________________________________________________________
Question #7: What would be a reasonable HbA1c target for an older patient with a
history of recurrent hypoglycemia, limited life expectancy, multiple co-morbid
conditions, advance chronic kidney disease, and history of strokes?
Question #8: Which of the following conditions increases the risk of hypoglycemia in
older adults?
Post-test #2
Question #6: What would be a reasonable HbA1c goal for a 72-year0old woman with a
complex health status, blood pressure of 140/90 mmHG, and fasting glucose of 100-150
mg/dL?
Question #3: Elderly patients with complex conditions are at what mortality risk with
tight blood sugar control?
_____________________________________________________________________________________________

Note. Selected LTCF nursing personnel participated in pre- and post-questionnaires.

For the second objective, the provider was expected to individualize the HbA1c targets for
each patient that met the inclusion criteria, use the standardized order sheets that delineated the
recommended test/procedures for routine T2DM care, and pursue investigation of underlying
conditions that may have caused a discordance between the HbA1c and finger stick glucose values.

INDIVIDUALIZED GLYCEMIC TARGETS FOR THE ELDERLY

49

Results of Pre/Post Test Questionnaires
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Figure 6. Results of the total scores from the pre/post-test questionnaires. This figure depicts the
comparison results determining the level of understanding obtained between the pre- and post-tests.
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Figure 7. Differences in total test scores by type of nurse. This figure depicts the test score
differences among nursing personnel (APRN, RNs, and LVNs).
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The APRN was assisted with setting individualized HbA1c targets for each patient as noted
in Table 8. There was 100% incorporation of the standardized order sheets into the charts.
Table 8
Individualized HbA1c targets set for each patient
_____________________________________________________________________________________________
HbA1c Target
Number of Patients
_____________________________________________________________________________________________
<7.5%
2
7.5%-8.0%
4
<8.0%
4
8.0%
12
_____________________________________________________________________________________________

Note. The table represents the individualized HbA1c target for the APRN’s patients.

However, of the 22 patients, only two patients had the individualized HbA1c annotated in the
progress notes (Figure 8). With regards to the APRN pursuing discordant HbA1c values, six of the
HbA1cs were identified as inaccurate. Five were further pursued to investigate the underlying
condition contributing to the discrepancy and one was missed (Figure 9). Because the HbA1c results
did not correlate with the patient’s daily finger stick glucose variability, the APRN provider ordered
further laboratory testing (complete blood count and iron panels) to determine the exact pathological
process contributing to the discordance. Conditions such as blood loss or hemolytic anemia can
falsely lower HbA1c results due to the shortened life span of the erythrocyte. Conversely, conditions
that contribute to increased erythrocyte survival such as iron deficiency anemia influence the
reliability of the HbA1c as a measure of glycemic control (ADA, 2017a, p. 50).
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HbA1c Modified Target Annotation

9%

91%

Yes

No

Figure 8. HbA1c modified target annotation in the progress notes. This figure illustrates the notation
of modified HbA1c targets found in the 22 selected patient’s progress notes.
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Figure 9. HbA1c accuracy. This figure illustrates the HbA1c accuracy for the 22 inclusive patient
chart audit.
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For objective three, the goal was for 80% (23 out of 29) of the nurses to recognize the
importance of routine T2DM care in the prevention/delay of diabetes related complications and to
use the routine T2DM checklist consistently in the selected LTCF residents. As previously discussed
only 13 (45%) of the nurses were able to participate in the in-services. Knowledge regarding the
importance of routine T2DM was assessed through a pre/post-test questionnaire with the results
cited in Figure 6 and 7. Similar to the standardized order sheets, there was 100% incorporation of the
checklists into the charts. The nurses’ knowledge regarding routine T2DM care of the target
population improved from a total score of 76 (pre-test) to 85 (post-test #1), and 100 points (post-test
#2).
Lastly, for the final objective, the goal was for 80% of the 22 patients to have appropriately
individualized HbA1c targets and have routine T2DM laboratory tests (HbA1c, urine albumin to
creatinine ratio, serum creatinine, and GFR) and physical exams (eye exam and foot exam) ordered
according to the recommendations set forth by the 2017 ADA Standards of Medical Care in
Diabetes. All the patients (100%) had an individualized HbA1c target annotated on the footnote of
the routine T2DM care checklist; but, the APRN provider was only able to annotate two in the
progress notes (Figure 8). Pertaining to routine T2DM test/care the chart audit indicated results were
as follows: there were 13 HbA1cs due to be ordered; 12 were ordered and 1 was missed (Figure 10);
only one renal panel was due and it was ordered (Figure 11); and five of the UACrs were due and
were all ordered (Figure 12). Among the unforeseen outcomes identified was that some of the labs
that were not due to be done and were inadvertently repeated. None of the foot or ophthalmology
exams were ordered as anticipated in all 22 patients. A favorable outcome was that the HbA1c, urine
albumin/creatinine, serum creatinine, and GFR were now triggered to be routinely ordered for all 22
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patients. Of note, the planned program evaluation was unable to be analyzed. The nurses did not
return any of the participant feedback forms which may have been the result of questionnaire fatigue.
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Figure 10. Breakdown of HbA1c tests from chart audit. This figure illustrates the breakdown of
HbA1c tests obtained from the 22 inclusive patient chart audit.
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Figure 11. Breakdown of renal panels form chart audit. This figure depicts the breakdown of renal
panels obtained from the 22 inclusive patient chart audit.
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Figure 12. Breakdown of UACrs from chart audit. This figure depicts the breakdown of urine
albumin/creatinine from the 22 inclusive patient chart audit

Discussion and Conclusions
Elderly patients with T2DM complicated by co-morbid conditions have higher rates of
morbidity and mortality compared to their younger counterparts. Intensive glycemic targets raise this
risk even further (ADA, 2017a). Results from the pre-test assessment revealed that there was a
general lack of awareness on what the appropriate HbA1c targets were for this population. This
finding provided verification that education on what the current ADA diabetes guidelines are was a
priority for the nursing staff. Similar concerns were raised by Hausken and Graue (2012) in that
there was significant need for nurses to be educated in the appropriate management of T2DM
patients who reside in LTCFs. The in-services provided a means of emphasizing that the goal of
treatment was to maintain quality of life, preserve independence, and minimize the risk of
cardiovascular events triggered by intensive glycemic control, which may result in hospitalization or
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death. Improvement in the overall total questionnaire scores indicated that knowledge regarding this
type pf care was increased. The QI project confirmed that a program specifically designed to
improve professional competence for nurses who care for T2DM patients in LTCFs is an effective
approach to improving knowledge.
Emphasis on the unreliability of the HbA1c as the indicator for glycemic control was
demonstrated by the provider by pursuing those that were inaccurate (5 out 6). For these patients, the
FS are the best measure of glycemic control. Vajen et al. (2012) note that treatment plans exclusively
based on HbA1c without reference to daily glucose logs makes it improbable that evidence-based
guidelines are being scrupulously adhered to. The FS values are the fail-safe method that pursues the
discordance between the HbA1c results and FS values. Medications will hopefully not be
discontinued based on the HbA1c results when in fact, the patient’s FS were uncontrolled. The
provider now has the awareness to order work-ups for anemia as one option to identify the root
cause of the discrepant values and to enable timely intervention. This information was of
significance since the chart audit revealed that 17 out of the 22 patients had CKD. This finding is a
valuable indicator that the patient may have CKD related anemia which can alter the accuracy of the
HbA1c results for these patients (Kliger et al., 2013).
For the other required T2DM routine care, use of the checklists and standardized order sheets
that specified the frequency of when the HbA1c, UACr, and RFPs was a decisive solution. Final
results of the chart audit showed that these labs were now ordered on a routine basis as per the ADA
guidelines. Order standardization may help lessen the burden for the APRN and provide the staff
some level of accountability in following the recommended routine care for elderly patients with
T2DM with poor health conditions. With regards to ophthalmology and podiatry referrals, the
outcome was poor related to APRN resistance and healthcare coverage restrictions. Of significance,
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64% (17 out of 22) patients had dementia. Thorpe et al. (2012) found that patients with dementia
were less likely to receive individual tests such as eye exams. Among the barriers cited were the
burden imparted on patients and caregivers in scheduling appointments and arranging transportation
compounded by the fact that cooperation in completing the actual exam may be an impossibility due
to cognitive deficits. It is important to highlight that the findings supported those of Haugsvedt
(2016) regarding the presence of discrepancies between diabetes guideline recommendations and
clinical diabetes practice in LTCFs, individualized treatment goals for HbA1c, and the establishment
of routine T2DM tests and exams.
Limitations
The QI project has limitations. One limitation was that there was a low rate of participation
from the nurses. In addition, the management communicated the in-service was not to interfere with
the routine care of the patients. Hausken and Graue (2012) cited that the success of a diabetes care
training for nurses in a LTCF is considerably dependent on organizational support of the educational
program. The in-service was originally scheduled to take place during the monthly staff meeting to
capture more nurses, but was canceled due to an unscheduled state inspection. The alternate viable
solution was to approach the nurses on a one-on-one basis at opportune times during their shifts.
The different educational needs of the nurses based on previous education and clinical
experience was also not considered and may have affected the total scores on the questionnaires. The
use of a pre/post-test questionnaire may not necessarily indicate that an improvement in performance
occurred but rather, measured the nurses’ ability to retain and recall the known facts regarding
T2DM care in LTCF residents.
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The small sample size of the patients selected for the QI project was also a limitation; but it
allowed for the QI project to be conducted in a relatively short amount of time and restricted
financial costs.
Lastly, the absence of a centralized electronic medical record had a negative impact on the
annotation of individualized HbA1c targets in the progress notes. Van Doorn-Klomberg et al. (2014)
found that the use of an electronic patient registry is a positive organizational determinant in the
provision of high-quality diabetes care. The silver lining for this project was that despite the barriers
faced by the APRN, she was supportive in the development, implementation, and evaluation of the
QI project.
Implications and Recommendations
What was derived from this QI project was that an educational in-service regarding
evidenced-based T2DM care for LTCF residents was needed by nurses. Future endeavors should be
focused on improving the delivery of preventive eye and foot exams for the residents. The essential
component to ensure preservation of the resident’s quality of life devoid of any diabetes related
complications demands collaborative effort from the administration, provider, and nurses. Gershater,
Pilhammar, and Riojer (2013) cited that the organization must take the responsibility in taking a
proactive approach in formally educating their nurses. It is counterintuitive that the focus of care is
provision of acute services for preventable complications. It needs to be communicated to
management and healthcare staff that preventive care translates to considerable monetary savings for
the LTCF and better health outcomes for its residents and that an investment in staff education may
promote these cost savings.
The implications of the QI project for the APRN in a DNP role is that DNP-prepared APRNs
are in a prime position to advocate for the delivery of high-quality, evidence-based care which can
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achieve positive health care outcomes for our patients. A comprehensive presentation of the role of
the DNP in the interdisciplinary team based on the American Association of Colleges of Nursing
(AACN) Essentials of Doctoral Education for Advanced Nursing Practice is presented in Table 9.
The presence of co-morbidities and functional limitations that complicate care in the elderly
patient with diabetes who resides in LTCF demands the utmost professional competence. As DNP
prepared APRNs, the ultimate challenge is to improve diabetes care in nursing homes. Among the
lessons learned from this QI project is that even a miniscule improvement can potentially contribute
to significant improvements in the LTCF residents’ quality of life and favorable organizational
support is needed to successfully achieve the objectives of a QI project to allow for its sustainability
in the long-run. The role of the APRN with a DNP role is to provide the leadership and expertise to
lay the foundation for exceptional diabetes care in LTCF residents.
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Table 9
Connection of QI project to DNP role
_____________________________________________________________________________________________
Essentials
Connection to DNP Role
_______________________________________________________________________________________________________
Essential I: Scientific Underpinnings
DNPs possess a comprehensive cache of knowledge from other areas
for Practice
of sciences that strengthens the foundation for exemplary practice
rooted in scientific knowledge that facilitates successful planning,
implementation, and evacuation of the QI project.
_____________________________________________________________________________________________
Essential II: Organization and Systems
DNPs are tasked with promoting improved health outcomes.
Leadership for Quality Improvement
Exceptional leadership skills and exhaustive knowledge of the
and Systems Thinking
processes involved in quality improvement is requisite criteria in order
to correct the identified deficiencies in the care of the elderly patients
with T2DM in LTCFs.
_____________________________________________________________________________________________
Essential III. Clinical Scholarship
DNPs base translation, application, and evaluation of quality
and Analytical Methods for
improvement programs from evidenced-based practice to solidify its
Evidenced-Based Practice
credibility and guarantee positive health outcomes for T2DM elderly
patients with co-morbid conditions residing in LTCFs.
_____________________________________________________________________________________________
Essential IV: Information Systems/
Where applicable, DNPs are proficient in the use and application of
Technology and Patient Care
Information/systems technology that can effect positive changes in our
Technology for the Improvement
faltering health care system.
and Transformation of Health Care
_____________________________________________________________________________________________
Essential V: Health Care Policy for
DNPs take a proactive role in influencing health policies that promote
Advocacy in Health Care
ethical and equitable care for the elderly. Preservation of quality of life
and dignity are the fundamental aspects of T2DM care for this
vulnerable group.
_____________________________________________________________________________________________
Essential VI: Interprofessional
DNPs are prepared to collaborate with other health care disciplines to
Collaboration for Improving Patient
achieve the mandate of the Institute of Medicine to achieve safe,
and Population Outcomes
timely, effective, efficient, equitable, and patient centered care in a
complex health care environment. DNPs are expected to assume a
leadership role of function as a highly skilled member of the team
where necessary.
_____________________________________________________________________________________________
Essential VII: Clinical Prevention
DNPs are qualified to meet the national call for health promotion and
and Population Health for Improving
disease prevention to achieve the national goal of improving the health
the Nation’s Health
of the population of the U.S. It can be initiated on a small scale at a
LTCF in elderly patients with T2DM complicated by co-morbidities.
_____________________________________________________________________________________________
Essential VIII: Advance Nursing
DNPs are primed to function in a variety of health care settings (LTCF)
Practice
with the distinct capacity to comprehensively integrate requisite
knowledge obtained from advance practice training; and apply it to an
area of specialized practice (T2DM in the elderly) to affect an
improvement in care.

_____________________________________________________________________________________________

Note. Adapted from The Essentials of Doctoral Education for Advanced Nursing Practice. Copyright
2006 by the American Association of Colleges of Nursing.
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Appendix A
Provider and Staff Questionnaire About Routine T2DM Care
Care of the Elderly with T2DM Questionnaire

1) Are you aware of the modified HbA1c targets in the elderly?

2) What do you think the HbA1c target should be?

3) Are you familiar with the diabetes treatment guidelines pertaining to periodic monitoring of
complications associated with T2DM such as eye exams, podiatry visits, HbA1c checks,
renal function studies, and annual microalbuminuria checks?

4) How often do you think their routine care tests should be ordered?
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Appendix B
Demographic Sheet for LTCF Chart Review
ID #: _____ Age: _____ Gender: _____
Co-morbid conditions:
Dementia ____

CVA/TIA _____ CAD _____

PVD _____ CKD _____ CHF _____

=======================================================================
Lab results:
HbA1c:

______________

Dates: _______________

______________

_______________

______________

_______________

Alb/cr: ______________

Dates: _______________

______________

_______________

______________

_______________

RFP: ______________

Dates: _______________

______________

_______________

______________

_______________

=======================================================================
Routine T2DM care:
Ophthalmology:

Podiatry:

Dates:

______________

Dates: ______________

______________

______________

______________

______________

______________

______________

Reason:
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Appendix C
HBA1c Treatment Goals for Older Adults with Diabetes
Patient characteristics
/health status
Health (few coexisting
chronic illnesses, intact
cognitive and functional
status)
Complex/intermediate
(multiple coexisting chronic
illness or 2+ instrumental
ADL impairments or mild-to
moderate cognitive
impairment)
Very complex/poor health
(LTC or end-stage chronic
illnesses or moderate to
severe cognitive impairment
or 2+ ADL dependencies)

Rationale

Reasonable HbA1c Goal

Longer remaining life
expectancy

<7.5% (58 mmol/mol)

Intermediate remaining life
expectancy, high treatment
burden, hypoglycemia
vulnerability, and fall risk

<8.0% (64 mmol/mol)

Limited remaining life
expectancy makes benefit
uncertain

<8.5% (69 mmol/mol)

Reminders:






Co-existing chronic illnesses are as follows: arthritis, cancer, congestive heart failure,
depression, emphysema, falls, hypertension, incontinence, stage 3 or worse chronic kidney
disease, myocardial infarction, and stroke.
End-stage-chronic illnesses are defined as stages 3-4 congestive heart failure or oxygen
dependent lung disease, chronic kidney disease requiring dialysis, or uncontrolled metastatic
cancer that may cause significant symptoms or impairment of functional status and
significantly reduce life expectancy.
Loose HbA1c targets higher that 8.5% (69 mmol/mol) is not recommended since this
predisposes the patient to more frequent higher blood sugar values that can lead to
glycosuria, dehydration, hyperglycemic osmolar syndrome, and poor wound healing.
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Appendix D
Conditions that Affect the Accuracy of HbA1c
Conditions
Hemoglobinopathies

Anemias affecting average lifespan
Hemolytic anemia or bleeding

Iron/B12/Folate deficiency
Blood transfusion

Description
Any inherited conditions that alter the oxygencarrying protein of the red blood cells such as
sickle cell anemia and thalassemias -> causes
for HbA1c results to be falsely lower
Causes increased red blood cell (RBC)
production -> more new RBCs relative to entire
RBC group --> less time for glycosylation ->
lower HbA1c
Causes decreased RBC production -> fewer
RBCs relative to entire RBC group -> more time
for glycosylation -> higher A1c
A1c is unreliable since this is not the patient’s
blood

Reminders:



The above clinical conditions will render the HbA1c test unreliable. Use the
fingersticks as the measure of glycemic control.
If a discrepancy between the HbA1c and fingersticks are identified, pursue
investigation of possible conditions mentioned above.
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Appendix E
LTCF Routine T2DM Checklist.
MICROVASCULAR COMPLICATION
MACROVASCULAR COMPLICATION
___ Retinopathy/Albuminuria
___ CAD/MI
___ Overt Nephropathy ___ Neuropathy
___ CVA/TIA
___ Gastroparesis
___ Prior Foot
___ PVD
Ulcer
___ Amputations
LABS
_____ Current
Hemoglobin A1c
Perform every 3 months
Due: __________
unless at goal. If patient is at
_____ Please order
target, order at least twice
annually.
_____ Current
Lipid panel
Perform annually.
Due: __________
_____ Please order
_____ Current
Due: __________
_____ Please order

Urine albumin-to-creatinine
ratio

Perform annually. DO NOT
order if patient has chronic
kidney disease.

_____ Current
Due: __________
_____ Please order

Serum creatinine and
calculated GFR

Perform annually.

Annual dilated and
comprehensive eye exam

Perform annually. It may be
done less frequently (every 23 years) following >1 normal
exams.
Perform annually.

EXAMS/REFERRALS
_____ Current
Due: __________
_____ Please order
_____ Current
Due: __________
_____ Please order
IMMUNIZATIONS
_____ Current
Due: __________
_____ Please order

Annual comprehensive foot
examination

Review eligibility for flu and
pneumonia vaccination.

Perform flu shots annually
and Pneumonia vaccines as
per guidelines. (Administer 1time dose to PCV13-naïve
adults at age 65 years,
followed by a dose of
PPSV23 12 months later).
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Appendix F
Simplified Order Form for Provider
Standing orders for diabetes mellitus type 2
LABORATORY TESTS:
⃝

Hemoglobin A1c every 3 months
⃝

Fasting lipid profile every year
⃝

Urine Microalbumin/Creatinine ratio every year (DO NOT order if patient has CKD)
⃝

Renal panel every year

IMMUNIZATIONS:
⃝

Influenza vaccine every year (as per facility schedule)
⃝

Pneumonia vaccine (Administer 1-time dose to PCV13-naïve adults at age 65 years,
followed by a dose of PPSV23 12 months later).

REFERRALS:
⃝

Dilated eye exam every year
⃝

Foot exam every year

OTHER:
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________
_______________________________________________________________________________

Provider: _____________________________

Date: ______________
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Appendix G
HbA1c Conversion Pocket Guide
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Appendix H
Pre/Post Learning Assessment Questionnaire
Pre/Post Test Questionnaire
1) Diabetes blood sugar targets for older adults must take into consideration that these patients:
a. Have higher rates of premature death and physical disability
b. Are more prone to co-existing illnesses such as hypertension, heart disease, and
stroke
c. Are significantly at increased risk for common conditions associated with the aging
process
d. All of the above
2) The HbA1c goal for most patients recommended by the American Diabetes Association
should be at:
a. <6.5%
b. <6%
c. <7.0
d. <8%
3) Elderly patients with complex health conditions are at __________ mortality risk with tight
blood sugar control.
a. Higher
b. Lower
4) Older people do not need to have regular eye exams, foot exams, and tests of kidney
functioning.
a. Yes
b. No

5) What are two effective ways of lowering the chances of hypoglycemia during transfer of
older patients from the hospital to long-term care facilities?
a. Telephone call.
b. Written medication dosing information and careful medication reconciliation.
c. Face to face conversation between care team members.
d. Texts specifying written medication dosing.
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Appendix H (continued)
6) What would be a reasonable HbA1c goal for a 72-year-old woman with a complex health
status, blood pressure of 140/90 mmHG, and fasting glucose of 100 to 150 mg/dL?
a.
b.
c.
d.

<7%
<7.5%
<8%
<8.5%

7) What would be a reasonable HbA1c target for an older patient with a history of recurrent
hypoglycemia, limited life expectancy, multiple co-morbid conditions, advanced chronic
kidney disease, and a history of strokes?
a.
b.
c.
d.

6%-7%
7%-8%
8%-9%
9%-10%

8) Which of the following conditions increases the risk for hypoglycemia in older adults?
a.
b.
c.
d.

Chronic liver disease
Chronic kidney disease
Heart Disease
Gastroparesis

9) There is potential to cause harm in lowering HbA1c in older adults to less than 6.5%.
a. True
b. False
10) The priority for older adults with T2DM is the avoidance and prevention of:
a.
b.
c.
d.

Cardiovascular complications
Hypoglycemia
Hyperglycemia
Hyperlipidemia
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Appendix I
Program Evaluation Form
Participant Feedback Form
Date of Session: Date 2017

Strongly
Disagree

Moderately
Disagree

Slightly
Disagree

Add your comments and suggestions
at the end of the form. Thank you.
KNOWLEDGE

Moderately
Agree
Slightly
Agree

Please indicate your level of agreement with each
statement below by checking the appropriate box.

Strongly
Agree

Didactic Topic: “Title”

I had sufficient knowledge of the discussion topic
before the presentation/session.
I have sufficient knowledge of the discussion topic
after the presentation/session.
CONFIDENCE
I felt confident with regards to the treatment of
complex diabetes patients before this session.
I feel confident with regards to the treatment of
complex diabetes patients after this session.
PRACTICE
I am likely to make changes to my treatment practice
for patients with diabetes based on what I learned in
the session today.
COMMENTS/SUGGESTIONS
The delivery method was appropriate.
The presenter demonstrated professionalism and
expertise in the subject area.
What comments or suggestions do you have to help
us improve this session?
Which best describes your professional background?
Physician
LVN

NP/CNS/PA
Non-medical

Registered Nurse
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Appendix J
LTFC Chart Audit Form
Checklist for LTCF chart audit

Subject
ID

Age/
Sex/
Race

Healthcare Co-morbid
Coverage conditions.

Was
HbA1c
level
ordered
quarterly?

Was HbA1c
discordance
investigated?

Was
individualized
HbA1c
annotated
in
progress
notes?

Annual
UACR &
renal panel
present?

Was
annual
dilated
retinal
exam
ordered?

Annual foot
exam
ordered?

1

Medicaid

Y

Y

n/a

N

n/a

N

N

2

Medicaid

Y

Y

n/a

N

Y/Y

N

N

3

Medicaid

Y

Y

N

N

Y/Y

N

N

4

Medicaid

Y

Y

Y

N

n/a

N

N

5

Medicaid

Y

Y

Y

N

n/a

N

N

6

Medicaid

Y

Y

Y

N

n/a

N

N

7

Medicaid

Y

Y

Y

Y

n/a

N

N

8

Medicaid

Y

Y

n/a

N

n/a

N

N

9

Medicaid

Y

Y

n/a

N

Y/Y

N

N

10

Medicaid

Y

Y

n/a

N

n/a

N

N

11

Medicaid

Y

Y

n/a

N

n/a

N

N

12

Medicaid

Y

Y

n/a

N

n/a

N

N

13

Medicaid

Y

Y

n/a

N

n/a

N

N

14

Medicaid

Y

Y

n/a

N

n/a

N

N

15

Medicaid

Y

Y

n/a

Y

n/a

N

N

16

Medicaid

Y

Y

Y

N

n/a

N

N

17

Medicaid

Y

Y

n/a

N

n/a

N

N

18

Private

Y

Y

n/a

N

Y/Y

N

N

19

Private

Y

Y

N

N

n/a

N

N
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Subject
ID

Age/
Sex/
Race

Healthcare Co-morbid
Coverage conditions.

Was
HbA1c
level
ordered
quarterly?

Was HbA1c
discordance
investigated?

Was
individualized
HbA1c
annotated
in
progress
notes?

79

Annual
UACR &
renal panel
present?

Was
annual
dilated
retinal
exam
ordered?

Annual foot
exam
ordered?

20

Medicaid

Y

Y

n/a

N

n/a

N

N

21

Medicare

Y

Y

n/a

Y

Y/Y

N

N

22

Medicaid

Y

Y

n/a

N

n/a

N

N

23
24
25

Notes:

INDIVIDUALIZED GLYCEMIC TARGETS FOR THE ELDERLY

Appendix K
Project Timeline
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Appendix L
2017 ADA Routine T2DM Care Guidelines
Laboratory Tests and Why?
Hemoglobin A1c (HbA1c)
measures the amount of glucose attached to
the red blood cells. I shows the average blood
sugar level for the past 2-3 months.
Urine check for microalbumin (alb/cr)
checks the urine for small proteins
(microalbumin) which is a hallmark for early
kidney damage.
Lipid Profile
measures the level of triglycerides and total
cholesterol.
Physical Exams and Why?
Retinal eye exam by ophthalmologist
exam involves taking a picture of the eye with
a special camera without having to dilate the
eye to check for signs of nerve damage to the
eye (retinopathy).
Foot exam by podiatrist
checks for foot problems such as calluses,
bunions, sores, and loss of sensation on the
feet to allow for early intervention and
prevent serious complications.
Immunizations and Why?
Flu and Pneumonia shots
people with diabetes are at high risk for
acquiring the flu and pneumonia vaccine

Frequency
Every three months.

Once a year.

Once a year of more often if needed.
Frequency
Once a year for those with retinopathy.
Every 2 years for those who do not have signs
of retinopathy.
Once a year.
More often if foot problems are identified.
Frequency
Every year for flu shot.
Pneumonia: 1 dose of PCV13 and at least 1
dose of PPSV23 depending on age and health
status.
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